Skip to main content
Home / CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Volume 7, Number 1
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 1, 2008

Articles

Editorial [ Neurodegenerative Disorders: From Molecules to Man (Part 2) Guest Editors: Giuseppe Di Giovanni, Vincenzo Di Matteo and Ennio Esposito ]
pp. 1-2(2)
Authors: Matteo, Vincenzo D.; Esposito, Ennio; Giovanni, Giuseppe Di

Favourites:
ADD

Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease
pp. 3-10(8)
Authors: Perry, George; Moreira, Paula I.; Santos, Maria S.; Oliveira, Catarina R.; Shenk, Justin C.; Nunomura, Akihiko; Smith, Mark A.; Zhu, Xiongwei

Favourites:
ADD

Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis
pp. 11-19(9)
Authors: Al-Chalabi, Ammar; Tripathi, Vineeta B.

Favourites:
ADD

Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinson's Patients?
pp. 20-27(8)
Authors: Qureshi, G. A.; Qureshi, Aftab A.; Devrajani, Bika Ram; Chippa, M. A.; Syed, S. Ali

Favourites:
ADD

Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
pp. 28-44(17)
Author: Giovanni, Giuseppe D.

Favourites:
ADD

Editorial [ Targeting Neurotrophic Factors, Their Receptors, and Signalling Pathways with Small Molecule Mimetics and Modulators to Achieve Neuroprotection and Regeneration Guest Editor: Stephen D. Skaper ]
pp. 45-45(1)
Author: Skaper, Stephen D.

Favourites:
ADD

The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors
pp. 46-62(17)
Author: Skaper, Stephen D.

Favourites:
ADD

Small Molecule Modulation of p75 Neurotrophin Receptor Functions
pp. 63-70(8)
Authors: Longo, Frank M.; Massa, Stephen M.

Favourites:
ADD

Targeting Neurotrophin Receptors in the Central Nervous System
pp. 71-82(12)
Authors: Mocchetti, Italo; Brown, Milton

Favourites:
ADD

MAP Kinase Pathways in Neuronal Cell Death
pp. 83-97(15)
Authors: Philpott, Karen L.; Facci, Laura

Favourites:
ADD

Stem Cells for the Treatment of Neurological Disorders
pp. 98-109(12)
Authors: Rao, Mahendra S.; Khanna, Aparna; Shin, Soojung

Favourites:
ADD

Tandem Repeat Peptide Strategy for the Design of Neurotrophic Factor Mimetics
pp. 110-119(10)
Authors: Williams, Gareth; Molina-Holgado, Francisco; Doherty, Patrick

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content